← Leaderboards
Richard M Mortensen
Brigham And Women'S Hospital
$5,060,137
Attributed
$5,060,137
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $705.9K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,060,137 · 4
By mechanism
R01$5,060,137 · 4
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joshua A Boyce$54,050,346
- Mark W Feinberg$27,862,974
- Francis W. Luscinskas$14,265,022
- Michael A Gimbrone$16,320,214
- James Kuang-Jan Liao$22,168,806
Others in their field
Top investigators on “Pathologic”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologicPathway InteractionsGenesIn VivoKnock-OutMineralocorticoid ReceptorCell TypeFibrosisInflammationHypertrophyAnti-InflammatoryAnti-Inflammatory AgentsMediator Of Activation ProteinMediatingCardiac MyocytesBaseAnimalsDisease ModelCardiovascular DiseasesCellsHeart HypertrophyHypertensionCardiacPhenotype
Grant awards (16)
Myeloid reprogramming in cardiac protection by aldosterone antagonists$387,500
R01 · FY2017 · HL · contact PI
Myeloid Reprogramming in Cardiac Protection by Aldosterone Antagonists$85,631
R01 · FY2017 · HL · contact PI
Myeloid reprogramming in cardiac protection by aldosterone antagonists$387,500
R01 · FY2016 · HL · contact PI
Myeloid reprogramming in cardiac protection by aldosterone antagonists$382,200
R01 · FY2015 · HL · contact PI
Myeloid reprogramming in cardiac protection by aldosterone antagonists$382,645
R01 · FY2014 · HL · contact PI
Metabolic responsive factors in cardiovascular disease$368,980
R01 · FY2009 · HL · contact PI
Metabolic responsive factors in cardiovascular disease$368,980
R01 · FY2008 · HL · contact PI
Metabolic responsive factors in cardiovascular disease$368,980
R01 · FY2007 · HL · contact PI
Metabolic responsive factors in cardiovascular disease$380,833
R01 · FY2006 · HL · contact PI
New G-Protein Signaling Pathways$325,027
R01 · FY2006 · HL · contact PI
New G-Protein Signaling Pathways$334,749
R01 · FY2005 · HL
New G-Protein Signaling Pathways$334,922
R01 · FY2004 · HL
New G-Protein Signaling Pathways$334,922
R01 · FY2003 · HL
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION$297,823
R01 · FY2001 · HL
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION$271,941
R01 · FY2000 · HL
MUSCARINIC AND ADENOSINE RECEPTOR SIGNAL TRANSDUCTION$47,504
R01 · FY2000 · HL